06 July 2017
Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, is pleased to announce that at the Company's Annual General Meeting held earlier today, 6 July 2017, all resolutions put to the meeting were duly passed.
For further information:
Quantum Pharma Plc | |
Chris Rigg, Chief Executive Officer | Tel: +44 (0) 1207 279 404 |
Gerard Murray, Chief Financial Officer | www.quantumpharmagroup.com |
ir@quantumpharma.co.uk | |
N+1 Singer (Nominated Advisor & Broker) | |
Sandy Fraser / Nick Owen / James White | Tel: +44 (0) 20 7496 3000 |
Media enquiries: | |
Buchanan | |
Henry Harrison-Topham / Sophie Cowles | Tel: +44 (0) 20 7466 5000 |
quantumpharma@buchanan.uk.com | www.buchanan.uk.com |
Notes to Editors
Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale and hospital markets. Quantum Pharma Plc operates through two divisions - Specials and Niche Pharmaceuticals - offering a portfolio of innovative and complementary products and services.
For further information, please visit www.quantumpharmagroup.com.
Quantum Pharma plc published this content on 06 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 July 2017 12:55:10 UTC.
Original documenthttp://ir.quantumpharmagroup.com/content/news/news_archive/2017/06-07-17.asp
Public permalinkhttp://www.publicnow.com/view/27A2B1C6908DB57345465C41AF8BDA8A8D024BE2